Poh-Fitzpatrick M B, Lamola A A
J Clin Invest. 1977 Aug;60(2):380-9. doi: 10.1172/JCI108787.
Excess erythrocyte protoporphyrins of human congenital erythropoietic protoporphyria and of griseofulvin-induced murine hepatic protoporphyria were found to be associated with hemoglobin and stroma fractions in similar relationships. More than 99.5% of total erythrocyte protoporphyrin was bound to hemoglobin in each case. However, profound differences were found when protoporphyrin concentration was measured in erythrocytes that had been segregated into populations of progressive age on discontinuous density gradients. In erythropoietic protoporphyria, porphyrin content diminished rapidly with age; in murine protoporphyria, the aging erythrocyte populations became progressively more porphyrin rich. In vitro diffusion of protoporphyrin from plasma across the intact erythrocyte membrane was demonstrated. The equimolar binding affinity of protoporphyrin to hemoglobin was shown to be 40 times that of protoporphyrin to serum albumin. This strong affinity provides the driving force for the observed transmembrane diffusion, and explains the high erythrocyte/plasma porphyrin ratio in murine hepatic protoporphyria. The opposite rapid efflux of intra-erythrocytic protoporphyrin into plasma previously shown in uncomplicated erythropoietic protoporphyria occurs despite this strong hemoglobin affinity, implying continuous efficient clearance of protoporphyrin from plasma by the liver. Furthermore, these and other data suggest that a hepatic synthetic source for any significant fraction of the blood protoporphyrin in erythropoietic protoporphyria is highly improbable.
人类先天性红细胞生成性原卟啉症和灰黄霉素诱导的小鼠肝原卟啉症中过量的红细胞原卟啉,被发现与血红蛋白和基质组分存在相似的关联关系。在每种情况下,超过99.5%的总红细胞原卟啉与血红蛋白结合。然而,当在不连续密度梯度上根据年龄将红细胞分离成不同群体后测量原卟啉浓度时,发现了显著差异。在红细胞生成性原卟啉症中,卟啉含量随年龄迅速减少;在小鼠原卟啉症中,衰老的红细胞群体中卟啉含量逐渐增加。证明了原卟啉可从血浆通过完整的红细胞膜进行体外扩散。原卟啉与血红蛋白的等摩尔结合亲和力被证明是其与血清白蛋白结合亲和力的40倍。这种强亲和力为观察到的跨膜扩散提供了驱动力,并解释了小鼠肝原卟啉症中红细胞/血浆卟啉比例较高的现象。尽管存在这种与血红蛋白的强亲和力,但之前在单纯红细胞生成性原卟啉症中显示的红细胞内原卟啉向血浆的快速外流现象仍然存在,这意味着肝脏能持续有效地清除血浆中的原卟啉。此外,这些以及其他数据表明,红细胞生成性原卟啉症中血液原卟啉的任何显著部分由肝脏合成的可能性极小。